Related Experiment Video
Updated: Jun 12, 2026

12:04
Assessment of Bone Fracture Healing Using Micro-Computed Tomography
Published on: December 9, 2022
Effects of μCT radiation on tissue engineered bone-like constructs.
Thomas P Kraehenbuehl1, Martin Stauber, Martin Ehrbar
1Institute for Biomechanics, ETH Zurich, Zurich, Switzerland.
Biomedizinische Technik. Biomedical Engineering
|June 24, 2010
Summary
Micro-computed tomography (μCT) imaging of engineered bone can impact cell survival and function. Even low X-ray doses (1.9 Gy) used for imaging may cause irreparable cellular damage, affecting research outcomes.
Area of Science:
- Biomaterials Science
- Cell Biology
- Medical Imaging
Background:
- Micro-computed tomography (μCT) is a non-destructive imaging technique for monitoring tissue-engineered bone constructs in situ.
- The impact of μCT's X-ray dose on bone development and experimental results is not fully understood.
Purpose of the Study:
- To develop a model system for assessing the in vitro effects of μCT imaging on engineered bone.
- To evaluate the impact of μCT irradiation doses on pre-osteoblastic cell survival and function.
Main Methods:
- Used pre-osteoblastic MC3T3-E1 cells embedded in 3D collagen type I matrices as a model system.
- Exposed cells to μCT imaging doses of 1.9 Gy and 7.6 Gy.
- Assessed cell survival at 2 hours and 2 days post-irradiation.
- Measured alkaline phosphatase (ALP) activity at 2 and 7 days post-irradiation.
Main Results:
- No significant reduction in cell survival was observed 2 hours after 1.9 Gy irradiation.
- Cell survival significantly decreased by 15% at 24 hours post-1.9 Gy irradiation.
- A dose of 7.6 Gy reduced cell survival by approximately 40% at 2 days.
- Alkaline phosphatase activity was significantly decreased 7 days after 1.9 Gy irradiation.
Conclusions:
- μCT imaging, even at low doses (1.9 Gy) necessary for adequate image quality, can induce significant, potentially irreparable, cellular damage.
- The findings suggest that μCT irradiation may influence the development of tissue-engineered bone constructs.
- Further research is needed to optimize μCT protocols to minimize biological effects in regenerative medicine applications.

